Puma Biotechnology Inc is a biopharmaceutical company that focuses on developing innovative treatments for incurable cancers. Their flagship product, Nerlynx, helps patients with HER2-positive breast cancer. With ongoing research and development, Puma aims to improve the quality of life for cancer patients worldwide.
